|
Name |
Debneyol
|
Molecular Formula | C15H26O2 | |
IUPAC Name* |
(2S)-2-[(2R,8R,8aR)-8,8a-dimethyl-2,3,5,6,7,8-hexahydro-1H-naphthalen-2-yl]propane-1,2-diol
|
|
SMILES |
C[C@@H]1CCCC2=CC[C@H](C[C@]12C)[C@@](C)(CO)O
|
|
InChI |
InChI=1S/C15H26O2/c1-11-5-4-6-12-7-8-13(9-14(11,12)2)15(3,17)10-16/h7,11,13,16-17H,4-6,8-10H2,1-3H3/t11-,13-,14-,15-/m1/s1
|
|
InChIKey |
XJXXJYGANFEEDD-NMFUWQPSSA-N
|
|
Synonyms |
Debneyol; 99694-82-3; (2S)-2-[(2R,8R,8aR)-8,8a-dimethyl-2,3,5,6,7,8-hexahydro-1H-naphthalen-2-yl]propane-1,2-diol; C09653; CHEBI:4343; DTXSID50331811; HY-N10058; CS-0254728; Q27106342
|
|
CAS | 99694-82-3 | |
PubChem CID | 442364 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 238.37 | ALogp: | 2.7 |
HBD: | 2 | HBA: | 2 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 40.5 | Aromatic Rings: | 2 |
Heavy Atoms: | 17 | QED Weighted: | 0.72 |
Caco-2 Permeability: | -4.42 | MDCK Permeability: | 0.00001360 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.125 |
30% Bioavailability (F30%): | 0.007 |
Blood-Brain-Barrier Penetration (BBB): | 0.334 | Plasma Protein Binding (PPB): | 94.30% |
Volume Distribution (VD): | 1.002 | Fu: | 3.21% |
CYP1A2-inhibitor: | 0.221 | CYP1A2-substrate: | 0.231 |
CYP2C19-inhibitor: | 0.132 | CYP2C19-substrate: | 0.862 |
CYP2C9-inhibitor: | 0.177 | CYP2C9-substrate: | 0.219 |
CYP2D6-inhibitor: | 0.051 | CYP2D6-substrate: | 0.202 |
CYP3A4-inhibitor: | 0.389 | CYP3A4-substrate: | 0.317 |
Clearance (CL): | 7.906 | Half-life (T1/2): | 0.639 |
hERG Blockers: | 0.008 | Human Hepatotoxicity (H-HT): | 0.16 |
Drug-inuced Liver Injury (DILI): | 0.07 | AMES Toxicity: | 0.004 |
Rat Oral Acute Toxicity: | 0.02 | Maximum Recommended Daily Dose: | 0.135 |
Skin Sensitization: | 0.797 | Carcinogencity: | 0.348 |
Eye Corrosion: | 0.352 | Eye Irritation: | 0.978 |
Respiratory Toxicity: | 0.117 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001437 | 0.554 | D07QKN | 0.279 | ||||
ENC001829 | 0.554 | D0K0EK | 0.250 | ||||
ENC005062 | 0.460 | D0B4RU | 0.236 | ||||
ENC004545 | 0.455 | D0CW1P | 0.235 | ||||
ENC004723 | 0.412 | D07DVK | 0.235 | ||||
ENC004725 | 0.412 | D0IT2G | 0.235 | ||||
ENC001832 | 0.403 | D0KR5B | 0.232 | ||||
ENC001183 | 0.403 | D0CZ1Q | 0.227 | ||||
ENC001924 | 0.403 | D0I5DS | 0.227 | ||||
ENC006100 | 0.400 | D03HYX | 0.222 |